New Haven has a well-developed network of detox and substance use treatment programs, ranging from DMHAS-licensed public facilities to private clinical programs affiliated with Yale University.
The Connecticut Department of Mental Health and Addiction Services (DMHAS) is the primary state agency responsible for licensing and overseeing all detoxification and substance use disorder treatment facilities, while the Connecticut Department of Public Health (CT DPH) provides additional licensure for private freestanding treatment centers.
Local oversight is coordinated through the South Central Connecticut planning region, one of nine regional planning areas established by the state.
New Haven has the highest concentration of publicly funded detox providers in the state. The APT Foundation at 1 Long Wharf Drive and Cornell Scott-Hill Health Center (SCRC) at 232 Cedar Street are the two primary safety-net detox providers, both accepting Medicaid, Medicare and uninsured patients on a sliding fee scale.
For people seeking immediate access to state-funded residential detox, DMHAS operates a 24/7 Access Line that facilitates placement and can prioritize transportation.
Moreover, the local treatment picture is shaped heavily by opioids. New Haven’s overdose fatality rate has historically run about three times the Connecticut statewide average, and the drug supply increasingly includes fentanyl, xylazine and emerging adulterants such as bromazolam.
For this reason, Yale School of Medicine researchers have been embedded in community care here since the 1990s, and the city is home to one of the first and largest syringe services programs in the country.
